Pages that link to "Q34854896"
Jump to navigation
Jump to search
The following pages link to Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice (Q34854896):
Displaying 22 items.
- Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection (Q34099129) (← links)
- Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy (Q34143589) (← links)
- Helicobacter pylori– inflammation, immunity and vaccines (Q35583570) (← links)
- Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy (Q35710205) (← links)
- Inflammation, immunity and vaccines for Helicobacter pylori (Q35878328) (← links)
- Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine (Q35919850) (← links)
- Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia (Q36050870) (← links)
- Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies (Q36101134) (← links)
- Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers (Q36444097) (← links)
- The current status of Helicobacter pylori vaccines: a review (Q36740010) (← links)
- In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori (Q37043683) (← links)
- Development of vaccines against Helicobacter pylori (Q37559634) (← links)
- Vaccinating against Helicobacter pylori in the developing world. (Q37591512) (← links)
- Vaccinating against Helicobacter pylori infection (Q37838238) (← links)
- Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis (Q37864241) (← links)
- Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori. (Q40094981) (← links)
- Recent advances that favor development of a vaccine for Helicobacter pylori infection (Q42919883) (← links)
- Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine (Q47888429) (← links)
- Influence of age and duration of infection on bacterial load and immune responses to Helicobacter pylori infection in a murine model (Q81162727) (← links)
- Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice (Q81912590) (← links)
- Helicobacter pylori: bacterial factors and the role of cytokines in the immune response (Q84763479) (← links)
- Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing (Q90136081) (← links)